Ozempic (semaglutide) is FDA approved for Type 2 diabetes and cardiovascular risk reduction and is often prescribed off-label for weight loss
This also makes it hard to predict which patent(s), if any, Novo Nordisk will enforce through the courts to prevent generics from competing on the market
GLP-1 medications can exacerbate diarrhea and loose stools, symptoms already common in post-cholecystectomy patients due to chronic bile acid diarrhea
Well also walk you through the mechanism of action that makes weight loss possible with semaglutide in the first place, then explore its health benefits, clinical trials, and potential risks or side effects
A doctor-supervised program ensures you receive the correct titration schedule, metabolic monitoring, and nutritional guidance needed to safely maintain muscle mass while losing fat